Advertisement

U.S. markets closed

S&P Futures
4,122.75
-1.75(-0.04%)
Dow Futures
32,734.00
-3.00(-0.01%)
Nasdaq Futures
13,016.25
-15.25(-0.12%)
Russell 2000 Futures
1,912.80
-1.80(-0.09%)
Crude Oil
90.15
-0.35(-0.39%)
Gold
1,808.10
-4.20(-0.23%)

Advertisement

Dynavax Technologies Corporation (DVAX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD

Add to watchlist

Visitors trend2W10W9M

17.02

-0.42

(-2.41%)

At close: 04:00PM EDT

17.05

+0.03

(+0.18%)

After hours:

07:59PM EDT

Advertisement

Full screen

Trade prices are not sourced from all markets

Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies

Chart Events

Bullishpattern detected

Williams %R

View all chart patterns

Performance Outlook

Previous Close	17.44
Open	17.05
Bid	16.76 x 3200
Ask	17.15 x 1100
Day's Range	16.26 - 17.33
52 Week Range	7.26 - 21.39
Volume	2,619,585
Avg. Volume	2,950,324

Market Cap	2.153B
Beta (5Y Monthly)	1.29
PE Ratio (TTM)	20.76
EPS (TTM)	0.82
Earnings Date	Nov 02, 2022 - Nov 07, 2022
Forward Dividend & Yield	N/A (N/A)
Ex-Dividend Date	N/A
1y Target Est	25.50

Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.

Fair Value

XX.XX

Undervalued

30% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for DVAX

View details

Research that delivers an independent perspective, consistent methodology and actionable insight

Related Research

Dynavax Technologies Corporatio
DVAX: Raising target price to $13.00DYNAVAX TECHNOLOGIES CORP has an Investment Rating of HOLD; a target price of $13.000000; an Industry Subrating of High; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of High.
Rating
Fair Value
Economic Moat
last monthArgus Research

All

Zacks
How Much Upside is Left in Dynavax Technologies (DVAX)? Wall Street Analysts Think 92%
The average of price targets set by Wall Street analysts indicates a potential upside of 92.2% in Dynavax Technologies (DVAX). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
- Wall Street Analysts See a 33% Upside in Raymond James Financial, Inc. (RJF): Can the Stock Really Move This High?
  Zacks
- Wall Street Analysts Think Targa Resources, Inc. (TRGP) Could Surge 35%: Read This Before Placing a Bet
  Zacks
Zacks
Dynavax Technologies (DVAX) Recently Broke Out Above the 20-Day Moving Average
When a stock breaks out above the 20-day simple moving average, good things could be on the horizon. How should investors react?
- Golar LNG (GLNG) Just Overtook the 50-Day Moving Average
  Zacks
- Encore Wire (WIRE) Just Reclaimed the 200-Day Moving Average
  Zacks
Motley Fool
Dynavax Technologies (DVAX) Q2 2022 Earnings Call Transcript
Before we begin, I advise you that we will be making forward-looking statements today based on our current expectations and beliefs, including, but not limited to potential market sizes and market share; market trends; impact of ACIP recommendations and timing of such impact; financial guidance and trends, including revenue, profitability, and sufficiency of current capitalization; timing and results of clinical trial starts and data readouts and potential future uses of CpG 1018 adjuvant. Joining me on the call today are Ryan Spencer, chief executive officer; Donn Casale, senior vice president of commercial; Rob Janssen, chief medical officer; and Kelly MacDonald, chief financial officer.